Bausch Health Companies Inc. Estimated Litigation Liability, Current
Bausch Health Companies Inc. (BHC) had Estimated Litigation Liability, Current of $326.00 million as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2023-08-03
- 2023-06-30: Estimated Litigation Liability, Current $326.00M.
- 2023-03-31: Estimated Litigation Liability, Current $326.00M.
- 2022-09-30: Estimated Litigation Liability, Current $323.00M.
- 2022-06-30: Estimated Litigation Liability, Current $1.54B.
| Period end | Estimated Litigation Liability, Current | Estimated Litigation Liability, Current as first filed |
|---|---|---|
| 2023-06-30 | $326.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $326.00M 10-Q · filed 2023-05-04 | |
| 2022-09-30 | $323.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.54B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.53B 10-Q · filed 2022-05-10 | |
| 2021-09-30 | $2.06B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $2.08B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $1.55B 10-Q · filed 2021-05-04 | |
| 2020-09-30 | $1.46B 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $1.50B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.42B 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $20.00M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $12.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $12.00M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $11.00M 10-K · filed 2019-02-20 | |
| 2018-09-30 | $11.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $54.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $81.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $243.00M 8-K · filed 2018-08-10 | |
| 2017-09-30 | $133.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $106.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $84.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $7.00M 10-Q · filed 2017-08-08 | |
| 2015-12-31 | $12.00M 10-K · filed 2017-03-01 | $12.30M 10-K · filed 2016-04-29 |
| 2014-12-31 | $8.00M 10-K · filed 2016-04-29 | |
| 2013-12-31 | $55.90M 10-K · filed 2015-02-25 | $55.92M 10-K · filed 2014-02-28 |
| 2012-12-31 | $16.28M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $1.30M 10-K · filed 2013-02-28 | |
| 2010-12-31 | $16.00M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $40.50M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $2.00M 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $7.95M 10-Q · filed 2010-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |